These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29967263)

  • 1. High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific
    Kather JN; Charoentong P; Suarez-Carmona M; Herpel E; Klupp F; Ulrich A; Schneider M; Zoernig I; Luedde T; Jaeger D; Poleszczuk J; Halama N
    Cancer Res; 2018 Sep; 78(17):5155-5163. PubMed ID: 29967263
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kather JN; Poleszczuk J; Suarez-Carmona M; Krisam J; Charoentong P; Valous NA; Weis CA; Tavernar L; Leiss F; Herpel E; Klupp F; Ulrich A; Schneider M; Marx A; Jäger D; Halama N
    Cancer Res; 2017 Nov; 77(22):6442-6452. PubMed ID: 28923860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of immunotherapy with combined three kinds of cells for operable colorectal cancer.
    Du XH; Liu HL; Li L; Xia SY; Ning N; Zou ZY; Teng D; Xiao CH; Li R; Xu YX
    Tumour Biol; 2015 Jul; 36(7):5679-85. PubMed ID: 25764087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel avenues in immunotherapies for colorectal cancer.
    Pardieck IN; Jawahier PA; Swets M; van de Velde CJ; Kuppen PJ
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):465-80. PubMed ID: 26582071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Insight into MAPK Inhibitors and Immunotherapy in Colorectal Cancer.
    Pancione M; Giordano G; Parcesepe P; Cerulo L; Coppola L; Curatolo AD; Conciatori F; Milella M; Porras A
    Curr Med Chem; 2017; 24(14):1383-1402. PubMed ID: 28245767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Going beyond microsatellite instability for immunotherapy in metastatic colorectal cancer: Consensus molecular subtypes and tumor mutational burden].
    Cohen R; Heran M; Pudlarz T; Hilmi M; Tournigand C; André T; Rousseau B
    Bull Cancer; 2019 Feb; 106(2):151-161. PubMed ID: 30638897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Blueprint to Advance Colorectal Cancer Immunotherapies.
    Le DT; Hubbard-Lucey VM; Morse MA; Heery CR; Dwyer A; Marsilje TH; Brodsky AN; Chan E; Deming DA; Diaz LA; Fridman WH; Goldberg RM; Hamilton SR; Housseau F; Jaffee EM; Kang SP; Krishnamurthi SS; Lieu CH; Messersmith W; Sears CL; Segal NH; Yang A; Moss RA; Cha E; O'Donnell-Tormey J; Roach N; Davis AQ; McAbee K; Worrall S; Benson AB
    Cancer Immunol Res; 2017 Nov; 5(11):942-949. PubMed ID: 29038296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of the β
    Benedicto A; Marquez J; Herrero A; Olaso E; Kolaczkowska E; Arteta B
    BMC Cancer; 2017 Dec; 17(1):827. PubMed ID: 29207960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.
    Roelands J; Kuppen PJK; Vermeulen L; Maccalli C; Decock J; Wang E; Marincola FM; Bedognetti D; Hendrickx W
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for colorectal cancer: where are we heading?
    Basile D; Garattini SK; Bonotto M; Ongaro E; Casagrande M; Cattaneo M; Fanotto V; De Carlo E; Loupakis F; Urbano F; Negri FV; Pella N; Russano M; Brunetti O; Scartozzi M; Santini D; Silvestris N; Casadei Gardini A; Puzzoni M; Calvetti L; Cardarelli N; Aprile G
    Expert Opin Biol Ther; 2017 Jun; 17(6):709-721. PubMed ID: 28375039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of colorectal cancer: new perspectives after a long path.
    Correale P; Botta C; Ciliberto D; Pastina P; Ingargiola R; Zappavigna S; Tassone P; Pirtoli L; Caraglia M; Tagliaferri P
    Immunotherapy; 2016 Nov; 8(11):1281-1292. PubMed ID: 27993089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments in immunotherapy for gastrointestinal cancer.
    Diaz JL; Wanta SM; Fishbein TM; Kroemer A
    Minerva Chir; 2015 Aug; 70(4):217-30. PubMed ID: 25916195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
    Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
    Front Immunol; 2018; 9():1288. PubMed ID: 29915603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomes.
    Kanterman J; Sade-Feldman M; Biton M; Ish-Shalom E; Lasry A; Goldshtein A; Hubert A; Baniyash M
    Cancer Res; 2014 Nov; 74(21):6022-35. PubMed ID: 25209187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer.
    Qian DC; Xiao X; Byun J; Suriawinata AA; Her SC; Amos CI; Barth RJ
    Clin Cancer Res; 2017 Jan; 23(2):399-406. PubMed ID: 27435399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent therapeutic advances in the treatment of colorectal cancer.
    Ciombor KK; Wu C; Goldberg RM
    Annu Rev Med; 2015; 66():83-95. PubMed ID: 25341011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy.
    Ciardiello D; Vitiello PP; Cardone C; Martini G; Troiani T; Martinelli E; Ciardiello F
    Cancer Treat Rev; 2019 Jun; 76():22-32. PubMed ID: 31079031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordination of intratumoral immune reaction and human colorectal cancer recurrence.
    Camus M; Tosolini M; Mlecnik B; Pagès F; Kirilovsky A; Berger A; Costes A; Bindea G; Charoentong P; Bruneval P; Trajanoski Z; Fridman WH; Galon J
    Cancer Res; 2009 Mar; 69(6):2685-93. PubMed ID: 19258510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer.
    Dufait I; Schwarze JK; Liechtenstein T; Leonard W; Jiang H; Escors D; De Ridder M; Breckpot K
    Oncotarget; 2015 May; 6(14):12369-82. PubMed ID: 25869209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.